Jonathan E. Lim
Net Worth

Last updated:

What is Jonathan E. Lim net worth?

The estimated net worth of Dr. Jonathan E. Lim is at least $21,305,014 as of 6 Dec 2023. He owns shares worth $19,865,014 as insider and has received compensation worth at least $1,440,000 in Erasca, Inc..

What is the salary of Jonathan E. Lim?

Dr. Jonathan E. Lim salary is $480,000 per year as Co-Founder, Chairman & Chief Executive Officer in Erasca, Inc..

How old is Jonathan E. Lim?

Dr. Jonathan E. Lim is 53 years old, born in 1972.

What stocks does Jonathan E. Lim currently own?

As insider, Dr. Jonathan E. Lim owns shares in one company:

Company Title Shares Price per share Total value
Erasca, Inc. (ERAS) Co-Founder, Chairman & Chief Executive Officer 12,899,360 $1.54 $19,865,014

What does Erasca, Inc. do?

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.

ERAS logo
ERAS
Erasca, Inc.
$1.54

Jonathan E. Lim insider trading

Erasca, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 278,150 $1.72 $478,418
Purchase
Common Stock 721,850 $1.69 $1,217,761
Purchase
Common Stock 1,000,000 $2.03 $2,026,000
Purchase
Common Stock 100,000 $2.75 $275,000
Purchase
Common Stock 100,000 $2.84 $284,000
Purchase
Common Stock 60,000 $3.86 $231,420
Purchase
Common Stock 40,000 $4.99 $199,600

Erasca key executives

Erasca, Inc. executives and other stock owners filed with the SEC:

  • Dr. David M. Chacko M.D. (42) Chief Financial Officer
  • Dr. Jonathan E. Lim (53) Co-Founder, Chairman & Chief Executive Officer
  • Dr. Michael D. Varney Ph.D. (67) Chairman of R&D, Scientific Advisory Board member and Director